Name: UMIN ID:
Unique ID issued by UMIN | UMIN000003271 |
---|---|
Receipt number | R000003947 |
Scientific Title | Multicenter PhaseII trial of erlotinib for elderly patients with advanced or recurrent non-small cell lung cancer. |
Date of disclosure of the study information | 2010/03/01 |
Last modified on | 2015/05/19 11:03:31 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/03/01 09:40:44 | ||
2 | Update | 2010/05/14 12:22:12 | Narrative objectives1 |
|
3 | Update | 2010/09/08 11:03:53 | Institutions |
|
4 | Update | 2011/03/09 11:54:33 | Last follow-up date |
|
5 | Update | 2011/09/02 11:43:39 | Organization Organization Category of Funding Organization Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
6 | Update | 2012/03/01 10:09:43 | Last follow-up date |
|
7 | Update | 2012/09/04 14:01:01 | Institute |
|
8 | Update | 2013/03/05 14:57:12 | Name of person sending information Name of person sending information Organization Organization Division name Division name TEL |
|
9 | Update | 2013/03/05 14:58:20 | Last follow-up date |
|
10 | Update | 2013/09/02 14:12:33 | Email |
|
11 | Update | 2013/09/02 14:15:09 | Last follow-up date |
|
12 | Update | 2014/09/29 11:17:07 | Recruitment status |
|
13 | Update | 2015/05/19 11:03:31 | Recruitment status Publication of results |